Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dYvACfbwoceShqalQUax

November 5, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
 
  ADVERTISEMENT  
Call for Tenders
The Australian Red Cross Blood Service wishes to advise providers of Floor Standing Blood Bag Centrifuges of a call for tender. To receive more details, prospective suppliers should email bloodcentrifugetender@redcrossblood.org.au by 2.00pm AEDT Friday 9 November 2012. All tenders must be received by 2.00pm AEDT Friday 14 December 2012.

  Science & Health 
  • Study examines chelation therapy for preventing heart problems
    A treatment called chelation therapy slightly reduces the risk of cardiac complications in survivors of heart attacks, according to a study funded in part by the National Heart, Lung and Blood Institute. Experts said the study was not sufficient to support chelation, which is intended to extract metals such as iron from the blood, as a standard therapy. In the study, the anticoagulant heparin was among the drugs used as part of treatment. Ethicist Art Caplan writes that the search for a dream fix downplays effective remedies such as weight loss and exercise. Bloomberg (11/5), NBC News/Vitals blog (11/5) LinkedInFacebookTwitterEmail this Story
  • Low-dose aspirin may help prevent blood-clot recurrence, study says
    Low-dose aspirin helps reduce the risk of recurrence of deep vein thrombosis and pulmonary embolism, according to an Australian study reported in the New England Journal of Medicine. "For every 1,000 patients treated for one year, aspirin can be expected to prevent about 20 to 30 episodes of recurrent major thrombotic events at the cost of about three significant bleeding episodes," said Dr. John Simes of the University of Sydney. The Times of India/Indo-Asian News Service (11/5) LinkedInFacebookTwitterEmail this Story
  • Stem cell treatment shows promise for sperm function
    A study in the journal Cell Stem Cell found that sperm-producing stem cells taken from monkeys before chemotherapy can be returned after treatment to improve reproductive function. The method resulted in working sperm from three out of five prepubescent monkeys and nine out of 12 mature monkeys. BBC (11/1) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Clinical Research: Understanding the Methodology Toolbox
Clinical Research: Understanding the Methodology Toolbox compiles articles of evidence-based research for use as an educational resource for those involved in clinical research, healthcare professionals and trainees in transfusion medicine and other medical specialties. Now in the AABB Marketplace.

  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
 
  ADVERTISEMENT  
Call for Tenders
The Australian Red Cross Blood Service wishes to advise providers of Data Loggers of a call for tender. To receive more details about the tender and how to participate, prospective suppliers should email dataloggertender@redcrossblood.org.au by 2.00pm AEDT Friday 9 November 2012. All tenders must be received by 2.00pm AEDT Friday 14 December 2012.

  Industry News & Practice 
  Government & Regulatory 
  • House lawmakers finalize compounding pharmacy bills
    Democrats in the House plan to introduce two separate bills that would require compounding pharmacies to meet the same sterility requirements as large drugmakers and subject them to increased FDA oversight. Federal investigators found contamination in two more drugs made by the New England Compounding Center. The Wall Street Journal (11/1) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: 2 sets of proposed standards available for comment
    The public comment period for the proposed draft "Standards for Immunohematology Reference Laboratories," eighth edition, and draft "Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens," second edition, will conclude on Dec. 28. The Immunohematology Reference Laboratory Standards Program Unit and the Molecular Testing Standards Program Unit are encouraging all interested individuals to submit their comments. The drafts are available on the AABB website. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
VP Patient ServicesBlood Centers of the PacificUS - CA - San Francisco
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Quality Source ConsultantBlood Systems, Inc.US - Nationwide
Quality SpecialistBlood Systems, Inc.US - NM - Albuquerque
Immunohematology Reference TechnologistLifeStreamUS - CA - San Bernardino
Director, Operational Policies and Procedures (Corporate Donor Recruitment)Blood Systems, Inc.US - AZ - Scottsdale
Help Desk SpecialistAABBUS - MD
Blood Bank Supervisors - Donor Collections Program & Transfusion ServiceUTMB HealthUS - TX - Galveston
Staff AccountantAABBUS - MD
Marketing Manager, Cellular TherapiesAABBUS - MD
Click here to view more job listings.

  SmartQuote 
Whoever is winning at the moment will always seem to be invincible."
--George Orwell,
British novelist and journalist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information